This article is a correction to:
Human Wharton's Jelly Stem Cell (hWJSC) Extracts Inhibit Ovarian Cancer Cell Lines OVCAR3 and SKOV3 in vitro by Inducing Cell Cycle Arrest and Apoptosis
Gauthaman Kalamegam1,2*
Khalid Hussein Wali Sait3
Farid Ahmed1Roaa Kadam1
Peter Natesan Pushparaj1Nisreen Anfinan3
Mahmood Rasool1
Mohammad Sarwar Jamal4
Muhammed Abu-Elmagd1Mohammed Al-Qahtani1- 1Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia
- 2Faculty of Medicine, Asian Institute of Medicine, Science and Technology (AIMST) University, Bedong, Malaysia
- 3Department of Obstetrics and Gynaecology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
- 4King Fahad Medical Research Centre (KFMRC), King Abdulaziz University, Jeddah, Saudi Arabia
by Kalamegam G, Sait KHW, Ahmed F, Kadam R, Pushparaj PN, Anfinan N, Rasool M, Jamal MS, Abu-Elmagd M and Al-Qahtani M (2018). Front. Oncol. 8:592. doi: 10.3389/fonc.2018.00592
Error in Figure
In the published article, there was an error in Figure 4A as published. In Figure 4A, the image representing hWJS-CM (100%) at 24h was identified to be the same as the hWJS-CM (50%) at 48h. The corrected Figure 4A and its caption appear below.
FIGURE 4
Figure 4 Representative phase contrast images of OVCAR3 cells treated with hWJSC-CM (A) and OVCAR3 cells treated with hWJSC-CL (B). There were more cell death and decreases in OVCAR3 cells treated with increasing concentrations of hWJSC-CM and hWJSC-CL with time. Thin black arrows indicate dead translucent cells; The magnified images (a–d) represent the respective boxed area (a-d) within the main figure and shows decrease in the size of cells, membrane damages and condensed or fragmented nuclei. hWJSC-CM: human Wharton’s jelly stem cells conditioned medium; hWJSC-CL, human Wharton’s jelly stem cell lysate.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: stem cells, cancer stem cells, cell cycle, cell migration, tumor spheres, gene expression, OVCAR3, SKOV3
Citation: Kalamegam G, Sait KHW, Ahmed F, Kadam R, Pushparaj PN, Anfinan N, Rasool M, Jamal MS, Abu-Elmagd M and Al-Qahtani M (2023) Corrigendum: Human Wharton’s Jelly stem cell (hWJSC) extracts inhibit ovarian cancer cell lines OVCAR3 and SKOV3 in vitro by inducing cell cycle arrest and apoptosis. Front. Oncol. 13:1171430. doi: 10.3389/fonc.2023.1171430
Received: 22 February 2023; Accepted: 01 March 2023;
Published: 20 March 2023.
Edited and Reviewed by:
Imtiaz Ahmad Siddiqui, Children’s Hospital Colorado, United StatesCopyright © 2023 Kalamegam, Sait, Ahmed, Kadam, Pushparaj, Anfinan, Rasool, Jamal, Abu-Elmagd and Al-Qahtani. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gauthaman Kalamegam, a2dhdXRoYW1hbkBrYXUuZWR1LnNh